Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

1.
2.

Effect of terbutaline on hyperpnoea-induced bronchoconstriction and urinary club cell protein 16 in athletes.

Simpson AJ, Tufvesson E, Anderson SD, Romer LM, Bjermer L, Kippelen P.

J Appl Physiol (1985). 2013 Nov;115(10):1450-6. doi: 10.1152/japplphysiol.00716.2013. Epub 2013 Sep 12.

PMID:
24030662
3.

Safety of sputum induction with isotonic saline in adults with acute severe asthma.

Wark PA, Simpson JL, Hensley MJ, Gibson PG.

Clin Exp Allergy. 2001 Nov;31(11):1745-53.

PMID:
11696051
4.

Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children.

Boner AL, Spezia E, Piovesan P, Chiocca E, Maiocchi G.

Am J Respir Crit Care Med. 1994 Apr;149(4 Pt 1):935-9.

PMID:
7908246
5.
6.

Novel albuterol multidose dry powder inhaler in patients with exercise-induced bronchoconstriction: A single-dose, double-blind, randomized, 2-way crossover study.

Ostrom NK, Taveras H, Iverson H, Pearlman DS.

Respir Med. 2015 Nov;109(11):1410-5. doi: 10.1016/j.rmed.2015.09.004. Epub 2015 Sep 8.

8.

Salbutamol and high-intensity treadmill running in nonasthmatic highly conditioned athletes.

Heir T, Stemshaug H.

Scand J Med Sci Sports. 1995 Aug;5(4):231-6.

PMID:
7552768
9.

A randomized clinical trial of magnesium sulphate as a vehicle for nebulized salbutamol in the treatment of moderate to severe asthma attacks.

Kokturk N, Turktas H, Kara P, Mullaoglu S, Yilmaz F, Karamercan A.

Pulm Pharmacol Ther. 2005;18(6):416-21.

PMID:
15953743
10.

Magnesium sulfate as a vehicle for nebulized salbutamol in acute asthma.

Nannini LJ Jr, Pendino JC, Corna RA, Mannarino S, Quispe R.

Am J Med. 2000 Feb 15;108(3):193-7.

PMID:
10723972
11.
12.

Overnight protection by inhaled salmeterol on exercise-induced asthma in children.

Carlsen KH, Røksund O, Olsholt K, Njå F, Leegaard J, Bratten G.

Eur Respir J. 1995 Nov;8(11):1852-5.

13.

Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group.

Edelman JM, Turpin JA, Bronsky EA, Grossman J, Kemp JP, Ghannam AF, DeLucca PT, Gormley GJ, Pearlman DS.

Ann Intern Med. 2000 Jan 18;132(2):97-104.

PMID:
10644288
14.

Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.

Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C.

Clin Ther. 2012 Aug;34(8):1655-66.e5. doi: 10.1016/j.clinthera.2012.06.005. Epub 2012 Jul 11.

PMID:
22789766
15.

Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline.

Richter K, Janicki S, Jörres RA, Magnussen H.

Eur Respir J. 2002 May;19(5):865-71.

16.

Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm.

Kemp JP, Dockhorn RJ, Busse WW, Bleecker ER, Van As A.

Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1612-5.

PMID:
7952623
17.

Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction.

Lavorini F, Geri P, Luperini M, Maluccio NM, Mariani L, Marmai C, Pistolesi M, Fontana GA.

Br J Clin Pharmacol. 2004 Nov;58(5):512-20.

18.

Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.

Blake K, Pearlman DS, Scott C, Wang Y, Stahl E, Arledge T.

Ann Allergy Asthma Immunol. 1999 Feb;82(2):205-11.

PMID:
10071526
19.

Salbutamol via Easyhaler is at least as effective as salbutamol via Turbuhaler in the treatment of histamine-induced bronchoconstriction.

Zetterström O, Lähelmä S, Keski-karhu J, Silvasti M, Ostling-kulling E, Ahonen A.

Respir Med. 2000 Nov;94(11):1097-102.

PMID:
11127498
20.

Effectiveness of nebulized furosemide added to nebulized salbutamol in children with acute asthma.

Nuhoğlu C, Yaşar Kiliç M, Ceran O.

Allergol Immunopathol (Madr). 2006 Mar-Apr;34(2):54-8.

PMID:
16606546

Supplemental Content

Support Center